13F-HR/A filed by Ghost Tree Capital, LLC
Ghost Tree Capital, LLC filed this 13F-HR/A for the quarter ended 2020-12-31, filed 2021-02-18, with 43 holding rows worth $448,776,000.
- Accession
- 0001387131-21-002623
- Filer
- CIK 1595851
- Filed
- 2021-02-18
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2020
A holdings report, amendment of type restatement, 43 entries on the cover page, a total value of $448,776,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $448,776,000 with VALUE read as thousands by filing date, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INVESCO QQQ TR | 46090E103 | COM | 100,000 | $31,374,000 | thousands by filing date | put |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,350,000 | $30,024,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 1,950,000 | $28,685,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 500,000 | $27,420,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 500,000 | $23,200,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 325,000 | $18,590,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 625,000 | $18,000,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 105,000 | $17,512,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 205,000 | $17,411,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 600,000 | $15,966,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 165,000 | $15,003,000 | thousands by filing date | |
| IMMUNOVANT INC | 45258J102 | COM | 300,000 | $13,857,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 600,000 | $13,854,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 250,000 | $13,005,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 475,000 | $12,946,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,100,000 | $12,353,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 50,000 | $10,982,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 50,000 | $10,982,000 | thousands by filing date | call |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 700,000 | $10,766,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 325,000 | $10,615,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 1,375,000 | $9,501,000 | thousands by filing date | |
| SURFACE ONCOLOGY INC | 86877M209 | COM | 1,000,000 | $9,240,000 | thousands by filing date | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 500,000 | $8,505,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 40,000 | $6,820,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 900,000 | $6,705,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS | G4444C102 | COM | 500,000 | $5,685,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 810,000 | $5,670,000 | thousands by filing date | |
| VISTAGEN THERAPEUTICS INC | 92840H202 | COM | 2,440,000 | $4,734,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 650,000 | $4,459,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 650,000 | $4,206,000 | thousands by filing date | |
| IMMUNIC INC | 4525EP101 | COM | 265,000 | $4,052,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 200,000 | $3,798,000 | thousands by filing date | |
| MODERNA INC | 60770K107 | COM | 35,000 | $3,656,000 | thousands by filing date | put |
| CURIS INC | 231269200 | COM | 425,000 | $3,481,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U404 | CMN | 200,000 | $3,206,000 | thousands by filing date | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 750,000 | $2,415,000 | thousands by filing date | |
| MILLENDO THERAPEUTICS INC | 60040X103 | COM | 925,000 | $1,980,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 400,000 | $1,956,000 | thousands by filing date | |
| APTEVO THERAPEUTICS INC | 03835L207 | COMMON | 50,000 | $1,833,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 200,000 | $1,574,000 | thousands by filing date | |
| OTONOMY INC | 68906L105 | COM | 200,000 | $1,294,000 | thousands by filing date | |
| SATSUMA PHARMACEUTICALS INC | 80405P107 | COM | 200,000 | $922,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 2,200 | $539,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-21-002485 | superseded | 2021-02-16 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001387131-21-002623 | this filing | 2021-02-18 | acceptance time not in the bulk data set |